acetylglucosamine has been researched along with cardiovascular agents in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brown, M; Che, P; Davis, ME; Gray, WD; Murthy, N; Ning, X | 1 |
Levit, RD; Taylor, WR | 1 |
Barba-de la Rosa, AP; Knabb, M; Martell-Gallegos, G; Perez-Aguilar, S; Rubio, R; Torres-Tirado, D; Velarde-Salcedo, J | 1 |
Bolanle, IO; Palmer, TM; Riches-Suman, K; Williamson, R | 1 |
1 review(s) available for acetylglucosamine and cardiovascular agents
Article | Year |
---|---|
Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Topics: Acetylglucosamine; Acetylglucosaminidase; Acylation; Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Cardiovascular Agents; Cardiovascular Diseases; Drug Delivery Systems; Enzyme Inhibitors; Glycosylation; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational | 2021 |
3 other study(ies) available for acetylglucosamine and cardiovascular agents
Article | Year |
---|---|
N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Drug Carriers; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines | 2011 |
A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational o
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Compounding; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines; Regeneration | 2011 |
G protein-coupled receptors mediate coronary flow- and agonist-induced responses via lectin-oligosaccharide interactions.
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Chromatography, Affinity; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Galactose; Galectins; Glycocalyx; Guinea Pigs; Lectins; Ligands; Mannose; Mannose-Binding Lectin; Mechanotransduction, Cellular; Models, Cardiovascular; Oligosaccharides; Proteomics; Receptors, G-Protein-Coupled; Receptors, N-Acetylglucosamine; Regional Blood Flow; Time Factors | 2014 |